151 related articles for article (PubMed ID: 26784850)
1. Dual targeting of solid lipid nanoparticles grafted with 83-14 MAb and anti-EGF receptor for malignant brain tumor therapy.
Kuo YC; Lee CH
Life Sci; 2016 Feb; 146():222-31. PubMed ID: 26784850
[TBL] [Abstract][Full Text] [Related]
2. Enhanced delivery of etoposide across the blood-brain barrier to restrain brain tumor growth using melanotransferrin antibody- and tamoxifen-conjugated solid lipid nanoparticles.
Kuo YC; Wang IH
J Drug Target; 2016 Aug; 24(7):645-54. PubMed ID: 26768307
[TBL] [Abstract][Full Text] [Related]
3. Inhibition against growth of glioblastoma multiforme in vitro using etoposide-loaded solid lipid nanoparticles with p-aminophenyl-α-D-manno-pyranoside and folic acid.
Kuo YC; Lee CH
J Pharm Sci; 2015 May; 104(5):1804-14. PubMed ID: 25694089
[TBL] [Abstract][Full Text] [Related]
4. Delivering etoposide to the brain using catanionic solid lipid nanoparticles with surface 5-HT-moduline.
Kuo YC; Hong TY
Int J Pharm; 2014 Apr; 465(1-2):132-42. PubMed ID: 24524828
[TBL] [Abstract][Full Text] [Related]
5. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
Kuo YC; Chen YC
Int J Pharm; 2015 Feb; 479(1):138-49. PubMed ID: 25560309
[TBL] [Abstract][Full Text] [Related]
6. Conjugation of melanotransferrin antibody on solid lipid nanoparticles for mediating brain cancer malignancy.
Kuo YC; Chao IW
Biotechnol Prog; 2016 Mar; 32(2):480-90. PubMed ID: 26701338
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor.
Kuo YC; Liang CT
Biomaterials; 2011 Apr; 32(12):3340-50. PubMed ID: 21296415
[TBL] [Abstract][Full Text] [Related]
8. Brain targeted delivery of carmustine using solid lipid nanoparticles modified with tamoxifen and lactoferrin for antitumor proliferation.
Kuo YC; Cheng SJ
Int J Pharm; 2016 Feb; 499(1-2):10-19. PubMed ID: 26721730
[TBL] [Abstract][Full Text] [Related]
9. Targeting delivery of saquinavir to the brain using 83-14 monoclonal antibody-grafted solid lipid nanoparticles.
Kuo YC; Ko HF
Biomaterials; 2013 Jul; 34(20):4818-30. PubMed ID: 23545288
[TBL] [Abstract][Full Text] [Related]
10. Solid lipid nanoparticles carrying chemotherapeutic drug across the blood-brain barrier through insulin receptor-mediated pathway.
Kuo YC; Shih-Huang CY
J Drug Target; 2013 Sep; 21(8):730-8. PubMed ID: 23815407
[TBL] [Abstract][Full Text] [Related]
11. Targeting delivery of liposomes with conjugated p-aminophenyl-α-d-manno-pyranoside and apolipoprotein E for inhibiting neuronal degeneration insulted with β-amyloid peptide.
Kuo YC; Lin CY
J Drug Target; 2015 Feb; 23(2):147-58. PubMed ID: 25268274
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel and naringenin-loaded solid lipid nanoparticles surface modified with cyclic peptides with improved tumor targeting ability in glioblastoma multiforme.
Wang L; Wang X; Shen L; Alrobaian M; Panda SK; Almasmoum HA; Ghaith MM; Almaimani RA; Ibrahim IAA; Singh T; Baothman AA; Choudhry H; Beg S
Biomed Pharmacother; 2021 Jun; 138():111461. PubMed ID: 33706131
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotection against degeneration of sk-N-mc cells using neuron growth factor-encapsulated liposomes with surface cereport and transferrin.
Kuo YC; Chou PR
J Pharm Sci; 2014 Aug; 103(8):2484-97. PubMed ID: 25041794
[TBL] [Abstract][Full Text] [Related]
14. Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment.
Chirio D; Gallarate M; Peira E; Battaglia L; Muntoni E; Riganti C; Biasibetti E; Capucchio MT; Valazza A; Panciani P; Lanotte M; Annovazzi L; Caldera V; Mellai M; Filice G; Corona S; Schiffer D
Eur J Pharm Biopharm; 2014 Nov; 88(3):746-58. PubMed ID: 25445304
[TBL] [Abstract][Full Text] [Related]
15. Cardiolipin-incorporated liposomes with surface CRM197 for enhancing neuronal survival against neurotoxicity.
Kuo YC; Liu YC
Int J Pharm; 2014 Oct; 473(1-2):334-44. PubMed ID: 24999054
[TBL] [Abstract][Full Text] [Related]
16. Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles.
Xin H; Sha X; Jiang X; Zhang W; Chen L; Fang X
Biomaterials; 2012 Nov; 33(32):8167-76. PubMed ID: 22889488
[TBL] [Abstract][Full Text] [Related]
17. Effect of human astrocytes on the characteristics of human brain-microvascular endothelial cells in the blood-brain barrier.
Kuo YC; Lu CH
Colloids Surf B Biointerfaces; 2011 Aug; 86(1):225-31. PubMed ID: 21524890
[TBL] [Abstract][Full Text] [Related]
18. Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy.
Kadari A; Pooja D; Gora RH; Gudem S; Kolapalli VRM; Kulhari H; Sistla R
Eur J Pharm Biopharm; 2018 Nov; 132():168-179. PubMed ID: 30244167
[TBL] [Abstract][Full Text] [Related]
19. Etoposide loaded solid lipid nanoparticles for curtailing B16F10 melanoma colonization in lung.
Athawale RB; Jain DS; Singh KK; Gude RP
Biomed Pharmacother; 2014 Mar; 68(2):231-40. PubMed ID: 24560352
[TBL] [Abstract][Full Text] [Related]
20. Targeting human brain cancer stem cells by curcumin-loaded nanoparticles grafted with anti-aldehyde dehydrogenase and sialic acid: Colocalization of ALDH and CD44.
Kuo YC; Wang LJ; Rajesh R
Mater Sci Eng C Mater Biol Appl; 2019 Sep; 102():362-372. PubMed ID: 31147008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]